Infectious Diseases

Bundibugyo virus: Why community trust is the only vaccine we have

Effective community engagement is critical for containing Bundibugyo virus outbreaks, according to new WHO operational guidance.

Influenza treatment: The single-dose option challenges multi-day adherence

The FDA approved the first single-dose generic influenza treatment, offering a new option for patients seeking convenient antiviral therapy.

Screwworm EUA: How targeting larval development changes prevention

The FDA issued Emergency Use Authorization for a drug to prevent New World screwworm infestations in horses, offering a critical short-term solution.

Treating screwworm: Why an OTC generic is now the frontline

The FDA issued an Emergency Use Authorization for a generic over-the-counter drug to treat New World screwworm infestations in companion animals.

The antibiotic paradox: More drugs won't solve resistance

Antibiotic resistance is a growing global health crisis, but a multi-pronged approach beyond novel compounds offers tangible solutions for clinicians.

Meningitis B: Why campus life shifts vaccine guidance for your patients

The MenB vaccine is now available for university students in Europe, targeting a population at increased risk for invasive meningococcal disease.

Black Death Survivors' Genetic Legacy Offers Clues for COVID-19 Resilience

Genetic analysis of medieval plague survivors reveals specific immune system adaptations that may offer insights into modern infectious disease resilience, including COVID-19.

Long COVID: Objective Biomarkers Challenge Psychosomatic Narrative

Emerging objective biomarkers for Long COVID, including immune dysregulation and microclots, directly contradict the long-standing psychosomatic explanation for patient symptoms.

New Virus Catalogue Identifies Top Pathogen Threats to Human Health

A comprehensive virus catalogue identifies pathogens posing the greatest threat to human health, prioritising those with pandemic potential.